Sonoma Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of SNOA for the last quarter is 3.39 M USD, and it's 1.40% lower compared to the previous quarter. The net income of Q1 24 is -1.14 M USD.